Fiche centre
University of Massachusetts Chan Medical School
Worcester — United States
Essais liés6clinical trials
VilleWorcesterlocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06907875
Essais cliniques associés
6| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| PROVIDUS — A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy | Myopathies | À vérifier | NCT07127978 | PROVIDUS — A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy | RECRUITING |
| EPI-321 | Myopathies | Phase 1/2 | NCT06907875 | FSHD — A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular Dystrophy | ACTIVE_NOT_RECRUITING |
| CABA-201 | Myasthénie | Phase 1/2 | NCT06359041 | RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis | RECRUITING |
| RGX-202 | Myopathies | Phase 2/3 | NCT05693142 | AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD) | ACTIVE_NOT_RECRUITING |
| CC-97540 | Lupus | Phase 1 | NCT05869955 | A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1) | ACTIVE_NOT_RECRUITING |
| Litifilimab | Lupus | Phase 3 | NCT05352919 | EMERALD — An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus | ENROLLING_BY_INVITATION |